Okay, let's tackle this question about the indication for administering Antisnake venom (ASV) in a viper bite. First, I need to recall the core concept here. Viper bites are known for causing coagulopathy and systemic envenomation. Antisnake venom is the specific treatment, but when is it indicated?

The core concept would be the management of envenomation from viper bites, focusing on the indications for ASV. Viper venom typically contains procoagulant enzymes that lead to consumption of clotting factors, resulting in a consumptive coagulopathy. ASV neutralizes the venom, so the indication is when there's evidence of envenomation, such as coagulopathy, systemic symptoms, or local effects.

The correct answer is likely when there's evidence of envenomation, such as abnormal coagulation tests (like prolonged PT/INR), systemic symptoms (hypotension, bleeding), or local swelling. The options might include incorrect ones like using it prophylactically for all bites, or only for neurotoxic symptoms (which are more common in elapid bites), or waiting for specific lab results.

Now, for the wrong options. Let's say Option A is "All viper bites require ASV immediately." That's incorrect because not all bites result in envenomation; some are dry. Option B might be "Only when neurotoxic symptoms are present," which is wrong because vipers cause coagulopathy, not neurotoxicity. Option C could be "Wait for lab confirmation of coagulopathy," which delays treatment; ASV should be given if there's clinical suspicion. Option D might be "Use in all patients with local swelling," but local swelling alone isn't enough; systemic signs are key.

Clinical pearl: Viper bites cause coagulopathy, so early ASV is crucial if envenomation is suspected. Don't wait for lab results if there are systemic symptoms. Distinguish from elapids which cause neurotoxicity.

Putting it all together, the correct answer is when there's evidence of envenomation, like coagulopathy or systemic symptoms. The explanation should cover the mechanism of viper venom, the role of ASV, and why each wrong option is incorrect.

**Core Concept** Antisnake venom (ASV) is indicated in viper bites only when there is confirmed or strongly suspected envenomation, characterized by systemic effects like coagulopathy, hypotension, or local signs such as extensive swelling and ecchymosis. Viper venom induces consumptive coagulopathy via procoagulant enzymes, necessitating ASV to neutralize circulating toxins.

**Why the Correct Answer is Right** The correct indication for ASV in viper envenomation is the presence of systemic symptoms (e.g., bleeding, shock, renal failure) or laboratory evidence of coagulopathy (e.g., prolonged PT/INR, thrombocytopenia). Early administration prevents irreversible complications like disseminated intravascular coagulation (DIC) and multiorgan failure. Local swelling alone without systemic signs does not warrant ASV, as not all viper bites result in envenomation.

**Why Each Wrong Option is Incorrect**
**Option A:** "All viper bites require immediate ASV" is incorrect because approximately

✓ Correct Answer: D. All of the above